re: Ann: Receives Health Canada Approval to U... fair enough , shc spent 70m so far on development and trials and the market values it at 25m. why bother to start with. Not many companies with 25m M/C would be listed on Nasdaq.
Add to My Watchlist
What is My Watchlist?